跳至主要内容
临床试验/CTRI/2022/09/045226
CTRI/2022/09/045226尚未招募未知

A Randomised Waitlist-Controlled Trial on the efficacy of Shirolepa in adults with Primary Insomnia

ochan Acharya0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Diagnosed with primary insomnia as per research diagnostic criteria for primary insomnia
  • 2. The insomnia severity index (ISI) score is more than eight points but less than 21 points

排除标准

  • 1. Indication of moderate/severe depressive or anxiety symptoms (score > 14 on
  • the depression scale, score > 10 on the anxiety scale and score > 19 on the
  • stress scale of DASS-21)
  • 2.Undergoing treatment or had taken any treatment for insomnia in < 3 months
  • 3. Pregnant or lactating women
  • 4.Nocturnal shift-work (i.e., working between 12:00 am and 6:00 am)

研究者

发起方
ochan Acharya

相似试验